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A B S T R A C T
GABA (γ-amino butyric acid) is the major inhibitory transmitter in the central nervous system and its
action is terminated by speciﬁc transporters (GAT), found in neurons and glial cells. We have previously
described that GAT-3 is responsible for GABA uptake activity in cultured avian Müller cells and that it
operates in a Na+ and Cl− dependent manner. Here we show that glutamate decreases [3H] GABA uptake
in puriﬁed cultured glial cells up to 50%, without causing cell death. This effect is mediated by ionotropic
glutamatergic receptors. Glutamate inhibition on GABA uptake is not reverted by inhibitors of protein
kinase C or modiﬁed by agents that modulate cyclic AMP/PKA. Biotinylation experiments demonstrate
that this reduction in GABA uptake correlates with a decrease in GAT-3 plasma membrane levels. Inter-
estingly, both GAT-1 and GAT-3 mRNA levels are also decreased by glutamate. Conditioned media (CM)
prepared from retinal neurons could also decrease GABA inﬂux, and glutamate receptor antagonists (MK-
801 + CNQX) were able to prevent this effect. However, glutamate levels in CM were not different from
those found in fresh media, indicating that a glutamatergic co-agonist or modulator could be regulating
GABA uptake by Müller cells in this scenario. In the whole avian retina, GAT-3 is present from embry-
onic day 5 (E5) increasing up to the end of embryonic development and post-hatch period exclusively
in neuronal layers. However, this pattern may change in pathological conditions, which drive GAT-3 ex-
pression in Müller cells. Our data suggest that in puriﬁed cultures and upon extensive neuronal lesion
in vivo, shown as a Brn3a reduced neuronal cells and an GFAP increased gliosis, Müller glia may change
its capacity to take up GABA due to GAT-3 up regulation and suggests a regulatory interplay mediated
by glutamate between neurons and glial cells in this process.
© 2015 Elsevier Ltd. All rights reserved.
1. Introduction
Astroglial cells are in close contact with neurons in every com-
partment of the brain, and evidence indicates that secreted factors
participate in a bidirectional communication throughout the nervous
system, including the retina (de Melo Reis et al., 2008). The concept
of gliotransmitters refers to active molecules that modulate several
neuronal functions, such as survival, differentiation and protec-
tion, and that are released by glial cells. In this sense, GABAergic
synapses within the central nervous system (CNS) are constituted
by a tripartite structure composed of a presynaptic neuron ﬁlled
with vesicles containing neurotransmitter, a post-synaptic compo-
nent with ionotropic GABAA (and GABAC in the retina) and/or
metabotropic GABAB receptors and glial cells in a complex envi-
ronment involved in GABAergic signaling. The removal and/or
inactivation of GABAergic inhibitory signals depend largely onmem-
brane transporters present not only in the presynaptic neuronal
terminals or in the glial compartment, but also on ependymal and
arachnoid cells (Eulenburg and Gomeza, 2010; Kanner, 2006).
Thus far, several GABA transporters have been described (GAT1-4
and BGT) (Madsen et al., 2010; Wu et al., 2006). All types are ex-
pressed in glial cells, with GAT-3 being the predominant glial isoform
(reviewed in Schousboe, 2003). The stoichiometry of operation of
GABA transport via GAT1-4 requires 2Na+:1Cl−:1GABA whereas for
BGT1 it requires 3Na+:2Cl−:1GABA (Karakossian et al., 2005; Loo et al.,
2000).
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GAT-1 and GAT-3 transporters are found in the retina of several
species, from skate (Birnbaum et al., 2005) to rodents (Brecha and
Weigmann, 1994; Pow et al., 2005), cat, monkey and human
(Biedermann et al., 2002; Casini et al., 2006; Pow et al., 2005; Zhao
et al., 2000). It belongs to a subfamily of three high-aﬃnity GABA
transporters GAT1-3. GABA transporters expressed in neurons display
a greater capacity of transport compared to glial transporters and
are particularly related to the recycling of the neurotransmitter into
GABAergic neurons. However, since GAT-1 is present in both neurons
and glial cells, it is not possible to distinguish the exact role of glial
and neuronal transporters. GABA is also taken up by astrocytes,
where it can be degraded or converted into glutamine (Eulenburg
and Gomeza, 2010). In addition to their contribution to control-
ling neurotransmission and GABA synthesis in retinal cells (Calaza
et al., 2001), glial transporters can release GABA in a reversal mode
of activity. This action is mediated by cell depolarization and might
be important in conditions of low levels of the transmitter (Richerson
and Wu, 2004). Therefore, the regulation of GABA concentration
in extra-synaptic sites due to the uptake by glial and neuronal
transporters might exert a modulatory action on the overall activ-
ity of GABAergic synapses and constitutes a potential therapeutic
target (Borden, 1996; Madsen et al., 2010; Schousboe, 2000).
We have previously described that GAT-3 operates in avianMüller
cells in culture in a Na+ and Cl− dependent manner, inhibited by
β-alanine and Zn2+, but not by NNC-711, a neuronal GAT-1 blocker.
Here we have extended the previous reports showing that plastic
changes in GAT-3 distribution can be observed when glia–neuron
interactions are disrupted. A regulatory interplay, based on
glutamatergic signaling, is presented as a possible factor able to
modify GABA uptake in the context of gliosis, excitotoxicity and
neuronal death.
2. Material and methods
2.1. Materials
[3H] GABA (Amersham Pharmacia Biotech, Piscataway, NJ, USA),
GABA, glutamic acid, PMA, Ro 31-8220 methanesulfonate salt,
calphostin C, staurosporine, forskolin and TPA (Sigma, St. Louis, MO,
USA) were used throughout this work. GAT-3 (AB1574) was from
Millipore. EZ-Link Sulfo-NHS-LC-Biotin, No-WeighTM Format (Cat.
21335, from Thermo Scientiﬁc), CaptAvidin agarose sedimented bead
suspension (Cat. 21386) and Fura-2 AMwere fromMolecular Probes,
Dulbecco’s modiﬁed Eagle’s medium (DMEM), fetal calf serum (FCS)
and gentamycin were obtained from Gibco (USA). Glutamate (Cat.
No. 0218), MK801 (Cat. No.0924), CNQX (Cat. No. 1045), and DNQX
were obtained from Tocris-Cookson (St. Louis, MO, USA). OPTI-
MEM was obtained from Life Technologies (Cat. No. 22600-050)
and PACAP was from Bachem (Bubendorf, Switzerland). All other
reagents were of analytical grade.
Fertilized white Leghorn eggs were purchased from a local hatch-
ery. The embryos were staged according to Hamburger and Hamilton
1951, and sacriﬁced by decapitation on embryonic day 9 (E9). The
eyes were removed and the retinas were dissected out in a Ca2+-
and Mg2+-free Hanks’ (CMF) solution. The retinas were then used
for culture preparations. We also used young chicks (up to 10 days)
injected with NMDA in the right eye. All experiments involving
animals were approved by the Animal Care and Use Committee of
the Biophysics Institute (CEUA permit number IBCCF-035). Efforts
were made to minimize animal suffering.
2.2. Retinal Müller glia
Retinal Müller glial cultures were generated from E9 chick retina
essentially as described before (De Sampaio Schitine et al., 2007;
Kubrusly et al., 2008; Reis et al., 2002). Brieﬂy, chick retina (0.25
retina per well) was dissociated using trypsin, and cells (neurons,
glia and progenitors) were seeded over 6 well, 35mm culture dishes
in DMEM containing 10% FCS. After 10 days, cell cultures were in-
cubatedwith 4mM ascorbic acid for approximately 1.5 h to eliminate
neurons, if necessary (Reis et al., 2002). After this stage, only glia
cells were found, this conﬁrmed through immunocytochemistry
analysis for glial or neuronal markers (not shown). Cultures were
subsequently washed with DMEM, and puriﬁed glial cultures were
obtained at E9C11-15 (cultures prepared from 9-day-old embryos
maintained for 11–15 days in vitro).
2.3. GABA uptake by Müller glia
Glial cultures were rinsed with Hank’s solution (128 mM NaCl,
4 mM KCl, 1 mMMgCl2, 3 mM CaCl2, 4 mM glucose, 20 mM HEPES)
and subsequently incubated in Hank’s solution with [3H] GABA
(0.25 μCi/plate) and 100 μM GABA as substrate. The speciﬁc drugs
used in the experiments were added 15 min before the [3H] GABA
incubation: PMA (0.1–2 μM), DHPG (10, 50 and 100 μM), MK801
(10 μM), DNQX (70 μM).
2.4. Live dead assay
A ﬂuorescence-based viability assay was performed as instructed
by the manufacturer (Live-dead assay; Invitrogen, Carlsbad, CA).
2.5. L-glutamate quantitation by HPLC–ED
Levels of L-glutamate in cultured cells and media were measured
by high performance liquid chromatography coupled with electro-
chemical detection (HPLC–ED; Shimadzu, Japan) as described elsewhere
(Monge-Acuña and Fornaguera-Trías, 2009). Brieﬂy, samples were
deproteinized with trichloroacetic acid (TCA; 10% w/v) and frozen at
−70 °C until further use. On the day of analysis, thawed samples
were mixed with an o-phthalaldehyde-sulﬁte derivatizing solution
(Rowley et al., 1995) and run through a C-18 reverse phase column
(Sigma-Aldrich, USA) before detection.
2.6. Western blot
Western blotting was done as previously described
(Pohl-Guimaraes et al., 2010). Brieﬂy,Müller glia cultureswerewashed
twice in phosphate buffer saline (PBS), homogenized in the pres-
ence of protease inhibitors and subjected to sodium dodecyl sulfate
(SDS)–polyacrylamide gel electrophoresis (PAGE). The proteins were
transferred to nitrocellulosemembranes, brieﬂy stainedwith Ponceau
red, washed with an appropriate buffer and pre-incubated with
5% casein and 1% bovine serum albumin (BSA) for 2 h at room
temperature in a shaker. The membranes were rinsed with Tris-
buffered saline containing Tween and incubated with the primary
antibodies against the GABA transporter GAT-3 (1:500) at 4 °C
overnight under agitation. Secondary horseradish peroxidase (HRP)-
conjugated antibodies (Sigma) were used to develop the protein band
corresponding to each of the expected molecular weights of the
proteins of interest, using ECL-plus (Pharmacia-Amersham).
2.7. Eye injections
Ten days post-hatched chicken was used to perform the in vivo
assays. The animals were injected with 5 μl of 50 mM NMDA in the
right eye while the animal received an injection of sterile PBS at
the same amount in the left eye. The animals were kept under
normal light cycle for 15 days and then sacriﬁced, by decapitation
and the eyes were removed.
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2.8. Tissue ﬁxation
Immediately after enucleation, the eyes were cut perpendicu-
larly, in order to form eye cups. After that, the eyes cups were ﬁxed
by immersion in 4% paraformaldehyde (PA) in 0.16 M phosphate
buffer (PB), pH 7.2, for 2 hours. Eyes cups were then rinsed with PB,
and then cryoprotected in sucrose (15 and 30%). After 24 hours, the
eyes cupsweremounted in OCT embeddingmedium (Sakura Finetek,
Torrance, CA), frozen and cryosectioned. Retina sections of 12–
16 μm were collected on poli-l-lysine (Sigma) pre-treated slides.
2.9. Immunocytochemistry
Immunoﬂuorescence was carried out as previously described
(Calaza et al., 2001; Kubrusly et al., 2008). Brieﬂy, Müller cell cul-
tures were rinsed in phosphate buffer saline (PBS, CaCl2 = 0.680mM,
KCl = 2.7mM, KH2PO4 = 1.47mM, MgSO4 = 0.49mM, NaCl = 136mM,
Na2HPO4 8 mM, pH 7.4) twice and then ﬁxed in 4% paraformalde-
hyde (PA) in 0.16M phosphate buffer, pH 7.2, for 10min. The cultures
were then rinsed 3 times with PBS and pre-incubatedwith 3% bovine
serum albumin (BSA) and 0.25% Triton for 30 min. Primary anti-
bodies for immunoﬂuorescence were incubated overnight in the
same blocking solution followed by a 2 h incubation with second-
ary antibodies. Primary antibodies were primary mouse monoclonal
antibody (IgG) reacting with chicken retina–2M6 (Müller glia
cell-speciﬁc antigen) diluted 1:500, a rabbit antibody against GAT-3
(Millipore) diluted 1:200, a rabbit antibody against GFAP (Spring,
M3782) diluted 1:100 and a primary mouse monoclonal antibody
(IgG) reacting with Brn3a. Secondary antibodies were goat anti-
mouse Alexa 488 and goat anti-mouse Alexa 555 (Invitrogen).
Cultured cells were counterstained with DAPI (4′-6-diamino-2
phenylindole) (Sigma) as a nucleic acid stain (1 μg/ml). Further
washes in PBSweremade and ﬁnally slides weremounted in sodium
n-propyl-gallate 0.2 M pH 7.2 in glycerol. Immunohistochemistry
was performed on slides with sections of control and experimen-
tal retinas. The slides were ﬁrst washed in sodium phosphate-
buffered saline (PBS). Then the tissue was pre-incubated with 5%
normal goat serum for 30 minutes, followed by overnight incuba-
tion with primary antibodies against GAT3 polyclonal rabbit
antiserum (1:100, Millipore) or monoclonal anti-2M6 (kindly pro-
vided by Dr. B. Schlosshauer; Max-Planck-Institute, Tübingen,
Germany). After several rinses in PBS, the sections were incubated
for 2 hours at room temperature with the appropriate secondary
antibodies as follows: donkey anti-mouse Alexa Fluor 488 anti-
body, anti-rabbit Alexa Fluor 594 (all 1:400 and all from Invitrogen).
2.10. RNA extraction and qRT-PCR
Total RNA was extracted from cells using the Trizol method. Real-
time quantitative reverse transcription-PCR (qRT-PCR)was performed
in one-stepwith 100ng of total RNA and using the KAPA SYBR Fast One
Step qRT-PCR system (KAPA BIOSYSTEMS KK4650) and using the Step
One Plus Real Time PCR System (Applied Biosystems). The qPCR proﬁle
consisted of an initial cDNA synthesis at 42 °C for 5min and 95 °C for
5min; then followed by 40 cycles of 95 °C for 3 s and 60 °C for 30 s. A
melt curve stage was added. We used the following speciﬁc primers
to amplify: chGat1F 5′-ATCCCTATGTTATGCTGCTTATCT-3′ and chGat1R
5′-CATCTAGCCAAACCTCAGAGT-3′. chGat 3F 5′-CTGGGTTTATGGC
AGCAATC-3′ and chGat3R 5′-GCACAAATACCTGGAGTTATGAC-3′. S17
chick ribosomal proteinmessenger RNAwas used as an internal control.
The oligonucleotides usedwere: S17F 5′-CCGCTGGATGCGCTTCATCAG-
3′ and S17R 5′-TACACCCGTCTGGGCAAC-3′. PCR products were
sequenced in order to verify their identity. The relative abundance of
GAT1 or GAT3 mRNA is expressed as sample versus a control in com-
parison to S17 chick ribosomal mRNA and was calculated using the
2−ΔΔCT.
2.11. Surface biotinylation and western blotting
To determine plasmamembrane expression of the GAT3 protein,
a 100 mm culture dish was used for each experimental condition
(n = 3). After treatment, one wash with 3 ml of ice-cold PBS, pH 8,
was performed; Müller glia monolayers were incubated in 3 ml of
EZ-Link Sulfo-NHS-LC-Biotin (0.14 mg/ml or 0.25 mM) solution in
PBS Ca2+, Mg2+, for 30 min in gently agitation at 4 °C. The reagent
was removed by washing the culture plates 3 times with 3 ml of
ice-cold 0.1 M L-glycine PBS, pH 8.0 with slow agitation. Subse-
quently, the cells were scraped and lysed in approximately three
times the pellet volumewith lysis buffer (50mM Tris–acetate buffer,
5 mM EDTA, pH 7, 0.3% (v/v) SDS, 0.3% (v/v) Triton X-100), the ho-
mogenization was carried out with a sonic dismembrator (Cat. FB50
Fisher Scientiﬁc) using three 15 amplitude pulses on ice. The lysate
was centrifuged at top speed in a tabletop centrifuge for 5 min at
4 °C, and the protein concentration of the supernatant was mea-
sured by the Bradford microplate assay. At least 500 μg of protein
was mixed with 30 μl of avidin-coated agarose particles. The sus-
pension was incubated at 4 °C overnight with slight agitation. The
ﬁrst supernatant was separated and used for non-biotinylated in-
tracellular proteins and after that the agarose particles were washed
3 times with 0.5 ml of 0.1% (v/v) Triton X-100 PBS, and centri-
fuged at 14,000× g for 4 min at 4 °C and the pellet was resuspended
in 10 μl of SDS–PAGE sample buffer. Samples were boiled for 5 min
and the same quantities of protein for input and supernatants and
the whole pellet of biotinylated proteins were loaded in the gels.
2.12. Single cell calcium imaging
Variations in the free intracellular calcium level ([Ca2+]i) were
evaluated in Müller cells following an adaptation of the protocol
reported by de Melo Reis et al. (2011) and essentially described for
DRG neurons and Schwann cells (Ribeiro-Resende et al., 2014). The
cells were loaded for 40 min with 5 μM Fura-2/AM (Molecular
Probes) in Krebs solution (132 mM NaCl, 4 mM KCl, 1.4 mMMgCl2,
2.5mM CaCl2, 6mM glucose, 10mMHEPES, pH 7.4) containing 0.1%
fatty acid-free bovine serum albumin (BSA) and 0.02% pluronic acid
F-127 (Molecular Probes) in an incubator containing 5% CO2 and 95%
atmospheric air at 37 °C. To obtain a complete hydrolysis of the probe,
cells rested at room temperature for 10 min in Krebs solution. The
15 mm glass coverslip (Marienfeld, Germany) containing the cells
was mounted on an RC-20 chamber in a P-5 platform (Warner In-
struments, Hamden, CT) on the stage of an inverted ﬂuorescence
microscope (Eclipse Ti-U; Nikon). The cells were continuously per-
fused with Krebs solution and stimulated with 2 mM glutamate.
Solutions were added to the cells by a gravity perfusion system, in-
cluding a set of syringes and a rotary selector valve. The variations
in [Ca2+]i were evaluated at intervals of 500 ms, by quantifying the
ratio of the ﬂuorescence emitted at 510 nm following alternate ex-
citation at 340 and 380 nm, using a Lambda DG4 illumination system
(Sutter Instrument, Novato, CA), a 40× objective and a 510 nm band-
pass ﬁlter (Semrock, Rochester, NY) before ﬂuorescence acquisition
with a 16-bit cooled EMCCD camera (Photometrics, Tuscon, AZ). Ac-
quired values were processed using MetaFluor software (Molecular
Devices, Sunnyvale, CA). Values for Fura-2 ﬂuorescence ratio were
calculated based on a threshold of 20% increase in the [Ca2+]i level
induced by the stimulus.
2.13. Data analysis
Statistical analysis was performed (Prism 6) using Student’s t test
or analysis of variance (ANOVA) followed by post hoc Tukey’s test
for multiple comparisons, or Dunnett’s multiple comparison post-
hoc test. Statistical signiﬁcance was taken at p < 0.05. Unless speciﬁed
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otherwise, the results are expressed as mean ± standard error (SEM)
of at least three separate experiments performed in triplicate.
3. Results
[3H] GABA uptake was carried out by avian Müller glia cultures
at stage E9C11-15. [3H] GABA accumulation byMüller glia is time and
Na+-dependent and inhibited by beta-alanine and Zn2+, but not by
NNC-711 (De Sampaio Schitine et al., 2007).We had previously noted
that [3H] GABA uptake by Müller glia is reduced by neuronal soluble
components secreted into neuron-conditioned media (CM) (De
Sampaio Schitine et al., 2007). Therefore, we investigatedwhich factors
could be involved in this effect. We asked if glutamate, a major ex-
citatory amino acid present in retinal neurons, could be that factor.
Indeed, addition of glutamate at a 2mM concentration to puriﬁed
culturedMüller cells reduced by 50% [3H] GABAuptake (Fig. 1A).More-
over, when Müller cultures were pre-incubated in CM containing
10 μM MK801, a non-competitive NMDA receptors antagonist, plus
70 μM DNQX (a competitive non-NMDA receptors antagonist), the
inhibition of [3H] GABA uptake observed with CM was no longer
present (Fig. 1A). In order to investigate if a strong membrane de-
polarization could induce a similar effect in Müller cells, we exposed
the cells to 80mM KCl. As depicted in Fig. 1B, [3H] GABA uptake was
reducedmimicking the CMand glutamate effects.Moreover, this effect
was completely inhibited in the presence of MK801 and DNQX
(Fig. 1B).
Wemeasured the glutamate contents in CM, by high performance
liquid chromatography–electrochemical detection (HPLC–ED). Gluta-
mate concentration was found to be similar to the concentration
found in fresh media (Fig. 1C). Therefore, the decrease in [3H] GABA
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uptake induced by CM was related to additional factors other than
glutamate.
We performed calcium imaging in puriﬁedMüller cells. As shown
in Fig. 1D, Müller glia cells plated on a 15mm glass coverslip were
loaded with fura-2 AM, washed with Krebs solution and selected
(colored circles); typical responses are shown for 30 cells when stimu-
lated with 2mM glutamate for 1 minute (arrow, Fig. 1E). Essentially,
all Müller glia cells were responsive to glutamate. In order to rule
out that the decrease in GABA uptake by glutamate could be related
to membrane dysfunction by cytotoxicity, we performed a live dead
assay inMüller glia cells in the presence of 1–2mMglutamate or 0.1%
H2O2. As shown (Fig. 1F), while glutamatewas not excitotoxic toMüller
cells compared to control levels, H2O2 completely eliminatedMüllerglia
after 30min incubation.
In order to characterize the glutamatergic receptors involved in
this effect, we performed dose–response curves for glutamate (Fig. 2A),
NMDA (Fig. 2D) or kainate (Fig. 2C) on [3H] GABA uptake by Müller
glia. All three excitatory amino acids were able to decrease the uptake
of [3H] GABA in a dose-dependent manner. The effect of NMDA was
dependent on the extracellular level of magnesium and entirely
blocked byMK-801 (Fig. 2E). Kainate or NMDA decreased the amount
of GABA taken up by Müller cells with an IC50 of approximately
30 μM, compatible with the previous reports (Lopéz-Colome et al.,
1993; Reis et al., 1995). The apparent IC50 for glutamate inhibition
of GABA uptakewas above 1mM, possibly reﬂecting effective removal
of glutamate by the glial cells. In addition, the effect of
glutamate in reducing [3H] GABA uptake was time-dependent
and inhibition could be observed after a 10 min of incubation,
and remained constant for up to 24 hrs (Fig. 2B). Addition of 3,5
dihydroxyphenylglycine (DHPG 0.05–0.1 mM), a metabotropic
group I glutamate receptor agonist, had no effect on [3H] GABA uptake
(Fig. 2F).
Protein kinase C (PKC) has been reported to phosphorylate GAT 1
in hippocampal cells (Beckman et al., 1999). Therefore, we decided
to expose Müller cells to phorbol myristate acetate (PMA), a PKC
activator. The results, shown in Fig. 3A, reveal an inhibition of [3H] GABA
uptake in the presence of PMA, with an IC50 value of approximately
300nM.However, additionof PKC inhibitors (100–500nMstaurosporine,
100 nM Calphostin C or 1 μM Ro 32–0432) in the presence of 2mM
glutamate did not revert the decrease in [3H] GABA uptake (Fig. 3B).
A fourth inhibitor was also used (0.1 μM bisindolylmaleimide I
(BIS I), and no effectwas seen in the presence of glutamate, not shown).
Therefore, glutamate is not operating on GAT-3 transporter through
PKC.
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of family I glutamatergic metabotropic receptors, showed no effect in [3H]-GABA uptake in puriﬁed Müller glia cells. *p < 0.05.
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Protein kinase A (PKA) has also been reported tomodulate the func-
tion of GABA transporters in the avian retina (Ferreira et al., 2014).
Indeed, Müller glia show functional D1 dopamine and PACAP recep-
tors that increase cyclic AMP (Kubrusly et al., 2005). Therefore,we asked
if forskolin, dopamine or PACAP agonists could revert the glutamate
inhibition in [3H] GABAuptake. As shown in Fig. 3C, none of these com-
pounds had an effect in cultured Müller glia in the presence of 2mM
glutamate. It was also recently reported that glutamate and ATP could
have interplay in terms of neuronal death via P2X7 in mixed Müller
glia–neuronal cultures from chick embryos (Anccasi et al., 2013), as this
effectwas inhibited by glutamatergic antagonists (MK-801 andDNQX).
Thereforewe asked if glutamate inhibition on [3H] GABA release could
bemediated by Ca2+ entry induced byATP on P2X7 receptors. As shown
in Fig. 3D, 0.01–1mMATP or 100 nM brilliant blue G (BBG, a P2X7 in-
hibitor) had no effect on the inhibitory action of glutamate uponGABA
uptake in puriﬁed Müller cells (Fig. 3D).
The results described thus far raised the question of whether the
inhibition of [3H] GABA uptake was due to a modiﬁcation in the
GAT-3 activity, or a change in the number of transporters in the cell
membrane. To answer this question, we performed a biotinylation
assay for GAT-3 (see Section 2) in Müller glia cells under stimula-
tion with glutamate for 30min. As shown in Fig. 4, 2 mM glutamate
decreases the amount of plasmamembrane GAT-3 levels when com-
pared to the non-stimulated condition.
In order to evaluate if glutamate also decreased the amount of
GAT-3 and GAT-1 mRNA levels, Müller glial cells were treated for
2 h with a ﬁxed 2 mM glutamate concentration. qRT-PCR analysis
showed that glutamate acting throughN-methyl-D-aspartate (NMDA)
as well as non-NMDA ionotropic receptors reduce both GABA trans-
porter mRNA levels (Fig. 5). As shown, TPA (a PMA analog) also
decreased the amount of GAT-3 and GAT-1 mRNA levels in Müller
glial cells. Together, these data point out that glutamate operates
at the transcriptional and post-translational levels decreasing the
amount of GAT-3 transporters, and therefore GABA uptake in Müller
glia cells.
Although both GAT-3 and GAT-1 transporters are expressed in
Müller glia cells, only GAT-3 is responsible for the [3H] GABA uptake
activity in puriﬁed glial cultures (De Sampaio Schitine et al., 2007).
Western blot analysis, using a speciﬁc antibody against GAT-3, re-
vealed that GAT-3 expression increases during retinal development.
It is ﬁrst detected at embryonic days 5–7 with a molecular weight
around 66 kDa, as shown for puriﬁed Müller glia (De Sampaio
Schitine et al., 2007). The intensity of the GAT-3 band increases
around E9 and E11 (Fig. 6). At E16 and in post-embryonic retinas,
the transporter is highly expressed (Fig. 6).
We ﬁnally evaluated the GAT-3 immunoreactivity pattern in the
adult chick retina. As shown in Fig. 7A, GAT-3 (red) is heavily ex-
pressed in the inner plexiform layer (IPL) and in some cell bodies
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Fig. 3. PKC inhibitors, modulators of cAMP/PKA or ATP do not alter glutamate inhibition of GAT-3 activity. Phorbol myristate acetate (PMA), a PKC activator, inhibits [3H] GABA
uptake with an IC50 value of approximately 300 nM. However, addition of PKC inhibitors (100–500 nM staurosporine, 100 nM Calphostin C or 1 μM Ro 32–0432) in the pres-
ence of 2 mM glutamate did not revert the decrease in [3H] GABA uptake (B). Forskolin, dopamine or PACAP, agents that increase cyclic AMP and activate PKA in Müller glia
cells had no effect in the [3H] GABA uptake presence of 2 mM glutamate (3C). Addition of 0.01–1mM ATP or 100 nM brilliant blue G (BBG, a P2X7 inhibitor) had no effect on
the inhibitory action of glutamate upon GABA uptake in puriﬁed Müller cells (D). N = 3 experiments performed in triplicate or quadruplicate; for Calphostin C (n = 4). *p < 0.05.
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in the inner nuclear layer (INL) where most of the amacrine cells
are located. In the control retina, no co-localization was observed
between GAT-3 (red) and the selective Müller glial marker 2M6
(green, Schlosshauer et al., 1991). A well-known protocol to induce
retinal neurodegeneration was then applied (Fischer and Reh, 2001).
After 15 days of the intraocular injection of NMDA (2 μmol) in the
right eye, the neurodegeneration described by Fischer and Reh (2001)
was conﬁrmed by the decrease in the retinal layers thickness,
observed with DAPI staining (Fig. 7B). After the retinal cell death,
a completely different pattern of GAT-3 and 2M6 expression ap-
peared (Fig. 7B and inset). In this pathological condition, 2M6-
positive radial ﬁbers were more frequently seen, and a substantial
expression of GAT-3 was now observed co-localizing with 2M6-
positive Müller end-feet near the ganglion cell layer (Fig. 7B and
inset). Indeed, the reduction in the number of positive cells for a
ganglion cell marker (Brn3a) in the ganglion cell layer (Fig. 7D) is
evident compared to the control retina (Fig. 7C). These results suggest
a GAT-3 up regulation in Müller cells, probably because of reac-
tive gliosis as shown for GFAP expression in the lesioned retina
(Fig. 7F) induced by neurodegeneration, compared to the control
retina (Fig. 7E). Interestingly, spots of GAT-3 transporter are also seen
at themembrane of puriﬁedMüller glia cells in culture 2 weeks after
plating (Fig. 7G).
4. Discussion
Müller cells in the retina completely surround glutamatergic and
GABAergic synapses (Boulland et al., 2002), suggesting their involve-
ment intheturnoverof thesetransmitters inthisstructure. In this report,
we demonstrate that glutamate, acting through its ionotropic recep-
tors, is involved in the regulation of glial GABA transporters. A sharp
decrease in [3H]GABAuptake inculturedMüllergliawasdetectedupon
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Fig. 7. Immunohistochemistry for GAT-3 in the chicken adult retina and in puriﬁed Müller cells. (A) In the control retina of the left eye that received an injection of sterile
PBS, GAT-3 (red) is observed in the inner plexiform layer (IPL) and in some cell bodies in the inner nuclear layer (INL). Müller cells can be visualized by using the 2M6
antibody (green) in radial ﬁbers in the control retina with no co-localization with GAT-3. (B) After the neurodegeneration induced by NMDA injection in the right eye GAT-3
expression (red) becomes more concentrated in the inner portions of the retina co-localizing with 2M6 labeling (green), probably in the endfeet of Müller cells (yellow,
white arrows). Inset: Higher magniﬁcation of the highlighted area in B showing the co-localization between GAT3 and 2M6 in the inner portion of the retina, possibly the
endfeet of Müller cells (yellow). (C) Expression of Brn3a (RGC marker, green) in the control retina, previously injected with PBS. (D) Neurodegeneration in the NMDA treated
retina as shown for Brn3a loss. (E) Expression of GFAP in the control retina, previously injected with PBS. (F) Under reactive gliosis, Müller cells over-express GFAP in the
lesioned retina previously injected with NMDA. (G) Puriﬁed Müller glia cells in culture labeled for 2M6 (green) express GAT-3 as well (yellow/orange dots). Retinal layers
are identiﬁed in the ﬁgure as follows: ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. N = 4.
Scale for B 50 μm, 7D 10 μm, 7F 50 μm 7G 10 μm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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glutamateexposure.Onecouldargue that any strongmembranedepo-
larization and/or persistent Ca2+ elevation inMüller cells would cause
effects similar to those of prolonged treatment with 2mM glutamate.
Indeed, 80mM KCl decreased [3H] GABA uptake in Müller glia. More-
over, thiseffectwascompletelyinhibitedbyionotropicglutamatereceptor
antagonists, suggesting that the [3H] GABA uptake reduction induced
by KCl in Müller cells involves glutamate release from these cells. In
supportof this interpretation, it ispertinent tomention thatKCl increas-
esATPandglutamate fromavianMullerglia (LoiolaandVentura, 2011).
The high glutamate concentration (above 1mM) needed to inhibit
GABA transport might be related to expression of functional gluta-
mate transporters in Müller cells (Gadea et al., 2004). In fact, when
selective and non-transportable agonistswere used tomimic the effect
of glutamate, a low EC50 was shown for NMDA and kainate (≅30 μM)
(Fig. 2) reinforcing our interpretation. We show that the decrease in
GABA uptake by glutamate is not due to membrane dysfunction
induced by cytotoxicity, as 2mM glutamate had no toxic effects to
Müller cells compared to control levels. In addition, previous data
from our lab indicate that kainate at 150 μM (that decreases GAT-3
transporters fromMüller glia cells, shown in Fig. 2) has no effect in the
choline transporter from mixed neuronal-Müller glia cells in culture
measured in terms of [3H] choline uptake (Loureiro-dos-Santos et al.,
2001). Also, glutamate stimulates the ascorbate transporter system
in the chick retina (Portugal et al., 2009) in a DNQX, but not MK801
dependentmanner. Therefore, the effect of glutamate inGAT-3 inMüller
cells from the chick retina is not due to non-speciﬁc membrane dys-
function. Finally, the contents of glutamate in the CM are not different
from the one found in DMEM-F12. This suggests that additional factors
present in the CM could release glutamate fromMüller glia thatwould
decreaseGABAuptake. Indeed, neuronal CM loses its capacity to reduce
GABAuptake in thepresence of NMDA (MK-801) or non-NMDA (DNQX)
antagonists (Fig. 1). One such factor could be D-serine, shown to be
released from the vertebrate retina that activates NMDA receptors
(Gustafson et al., 2014).
It has been shown that the Müller cells are the major supportive
glia for neurons in the adult retina. After a widespread neuronal
degeneration inducedwith intraocular injection of NMDA in the chick
retina (Fischer and Reh, 2001), Müller cells re-enter the cell cycle and
behave like progenitors, giving rise to new cells.Moreover, it was found
that themammalian retina also has potential to regenerate inner retinal
neurons in vivo from Müller glia (Karl et al., 2008).
Previous data from our lab have shown that Müller cells are
neurochemically plastic. Cultured Müller cells express neuronal
markers such D1A and D1B dopamine receptors under conditions in
which neurons are eliminated (Kubrusly et al., 2005). Müller glia cells
also express tyrosine hydroxylase and L-dopa decarboxylase, enzymes
involved in dopaminergic transmission (Kubrusly et al., 2005). Due
to the acquisition of dopaminergic function, these cells have re-
cently been used for cell therapy in a mouse model of Parkinson
disease (Stutz et al., 2014). These data suggest a complex neuron–
glia signaling that regulates the differentiated phenotype of theMüller
cells, especially the expression of proteins associated with the do-
paminergic machinery (Kubrusly et al., 2008; Reis et al., 2007). Based
on this scenario, we show in the present work that Müller glia also
change their standard features related to the GABAergic system.
As opposed to mammalian retina (Andrade da Costa et al., 2000),
Müller glia from the chick retina cannot take up GABA (Calaza et al.,
2001;Marshall and Voaden, 1974). CulturedMüller glia from the chick
retina express both GAT-1 and GAT-3, but only GAT-3 seems to be
active as based on pharmacological evidence (De Sampaio Schitine
et al., 2007). Reactive gliosis is an important event after lesion in the
nervous system, particularly in the retina (Bringmann et al., 2009;
Fischer and Reh, 2001). Even though chickenMüller cells do not take
up GABA in vivo, in the absence of neurons, these cells are capable
to take up the neurotransmitter, suggesting the existence of neuron–
glia communication that halts in situ glial GABA uptake activity.
It has been described that GAT-1 is subject to multiple forms of
regulation, via second messengers and protein–protein interac-
tions (Hu and Quick, 2008). The various forms of regulation include
plasma membrane transporter translocation rates. In this context,
PKC is associated with a decrease in GAT1 transport capacity and
an accumulation of the protein in the intracellular compartment
(Beckman et al., 1999). Interestingly it is known that through the
use of selective muscarinic agonist receptors for M1, M3 and M5
subtype family, a decrease in GABA uptake activity in hippocam-
pus is present, and that this effect is related to a decrease in the cell
surface expression of GAT-1 shown through protein biotinylation,
through the involvement of PKC (Beckman et al., 1999). In the present
communication, glutamate decreases GAT-3 at the cell surface, with
the expected increase in the supernatant fraction (Fig. 4).
Glutamate also modulates GAT-1 activity through metabotropic
receptors. Treatment of hippocampal rat cultures with trans-ACPD
or DHPG, which are speciﬁc agonists for group 1 metabotropic re-
ceptors, decreases GAT -1 function (Beckman et al., 1999). Although
Müller cells express group I metabotropic glutamate receptors (Ji
et al., 2012), no effect in the decrease in GABA uptake promoted by
glutamate could be detected. In addition, PMA decreased [3H] GABA
uptake in a dose-dependent manner in Müller cells. However, the
effect of glutamate inhibition on [3H] GABA uptake was indepen-
dent of PKC, based on three different selective inhibitors (Fig. 3). Also,
a fourth inhibitor (BIS I) had no effect on the effect promoted by
glutamate on GAT-1 and GAT-3 mRNA (not shown).
Previous data from our lab have shown that Müller cells are
neurochemically plastic. Cultured Müller cells express neuronal
markers such D1A and D1B dopamine and PACAP receptors under
conditions in which neurons are eliminated (Kubrusly et al., 2005).
As these receptors increase cAMP, we asked if cAMP/PKA could
operate on [3H] GABA uptake, but there was no effect in the pres-
ence of forskolin, PACAP, SKF (a D1 receptor agonist) reverting the
inhibition promoted by glutamate.
More subtle interactions between glutamate and glial GABA trans-
port had been considered in other regions of the brain balancing
excitatory and inhibitory signals in slice preparations from the hip-
pocampus (Héja et al., 2012), cerebral cortex (Unichenko et al., 2013),
and striatum (Wójtowicz et al., 2013). Here, we show that gluta-
mate reduces GAT-3 and GAT-1 mRNAs in puriﬁed Müller glia via
ionotropic glutamate receptors (Fig. 5).
It was reported that glutamate intermediates neuronal death via
P2X7 in mixed Müller glia–neuronal cultures from chick embryos.
This effect was inhibited by glutamatergic antagonists (MK-801 and
DNQX). Moreover, [3H]-D-aspartate (a glutamate analog) uptake is
reduced by ATP in cultured glial cells (Anccasi et al., 2013). Al-
though ATP activates P2X7 receptors in the millimolar range in a
Ca2+ dependentmanner inmacrophages, neurons or astrocytes (Alves
et al., 2014), addition of this nucleotide had no effect on the glu-
tamate inhibition of [3H] GABA uptake (Fig. 3D). In addition, 100 nM
brilliant blue G (BBG) had no effect on the glutamatergic inhibition.
Even though GAT-3 is detected in the avian retina during develop-
ment and in the mature retina, immunoreactivity for this transporter
has not been detected inMüller cells in the intact tissue, as measured
byitsco-localizationwith2M6,aMüllerspeciﬁcantigen.However, lesion
of retinal neurons promotes an impressive increase in GAT-3 immu-
noreactivity in Müller ﬁbers. This phenomenon is likely due to the
interruption of proper interaction of retina neurons with the Müller
system, as clearly observed with the puriﬁed Müller cell model de-
scribed earlier. Indeed, Brn3a labeling identiﬁes a loss of RGCs in the
retina injectedwithNMDA(Fig. 7D), followedbyan increase in thecon-
tents of GFAP (Fig. 7F). Therefore, any in vivo lesions (for instance, in
ischemia)mayinfactbepotentiatedbydecreasedinhibitorytonuscaused
by increased GABA uptake by Müller cells. It would be interesting to
consider,pharmacological interventions thatcouldreduceGABAuptake
and improve the inhibitorystrength, in lesionedareas,with thepurpose
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of reducing excitotoxicity. The avian retina system seems to be a good
model to approach these concepts. Experiments currently in progress
in our labs are aimed at characterizing themolecular mechanisms in-
volvedinglutamate-dependentGAT-3plasmamembranelevelreduction.
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